HBIO
HARVARD BIOSCIENCE INCCompany Information
- Company Name
- HARVARD BIOSCIENCE INC
- CIK
- CIK0001123494
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- HBIO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3826
- SIC Description
- Laboratory Analytical Instruments
- Ticker
- HBIO
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-17
- Last sale
- —
- Shares purchased (TTM)
- 28,475
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,173,965
- Shares outstanding
- 4,526,000
- Ownership
- 25.94%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- 30.83%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 7 | 7 | 9 | 7 | 7 | 6 | 4 | 5 | 4 | 4 | 4 | 5 | ||||||
| Accounts Receivable Net Current | 15 | 15 | 16 | 12 | 12 | 13 | 15 | 13 | 12 | 15 | 16 | 15 | ||||||
| Inventory Net | 22 | 22 | 21 | 22 | 22 | 23 | 23 | 26 | 25 | 24 | 25 | 26 | ||||||
| Other Assets Current | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 4 | ||||||
| Assets Current | 46 | 47 | 48 | 44 | 45 | 45 | 45 | 47 | 46 | 48 | 49 | 50 | ||||||
| Property Plant And Equipment Net | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | ||||||
| Operating Lease Right Of Use Asset | 6 | 7 | 7 | 8 | 7 | 7 | 6 | 7 | 4 | 4 | 5 | 5 | ||||||
| Goodwill | 9 | 9 | 10 | 10 | 10 | 9 | 56 | 57 | 57 | 57 | 57 | 56 | ||||||
| Intangible Assets Net Excluding Goodwill | 6 | 7 | 8 | 8 | 9 | 10 | 11 | 12 | 13 | 15 | 16 | 17 | ||||||
| Other Assets Noncurrent | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 6 | 8 | ||||||
| Assets | 76 | 78 | 80 | 78 | 80 | 80 | 127 | 131 | 129 | 133 | 137 | 140 | ||||||
Liabilities Current | ||||||||||||||||||
| Secured Debt Current | - | - | 0 | 34 | 35 | 36 | 37 | 4 | 4 | 4 | 6 | 3 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | 1 | 1 | 2 | ||||||
| Accounts Payable Current | 6 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | ||||||
| Contract With Customer Liability Current | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 4 | ||||||
| Other Liabilities Current | 15 | 15 | 15 | 12 | 12 | 11 | 9 | 10 | 9 | 10 | 11 | 8 | ||||||
| Liabilities Current | 25 | 24 | 22 | 54 | 55 | 56 | 55 | 23 | 23 | 26 | 27 | 24 | ||||||
| Long Term Debt Noncurrent | 37 | 36 | 36 | - | - | - | 0 | 34 | 32 | 32 | 31 | 35 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 7 | 5 | 5 | 5 | 4 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | ||||||
| Liabilities | 69 | 68 | 66 | 64 | 64 | 65 | 63 | 66 | 62 | 64 | 64 | 65 | ||||||
| Preferred Stock Value | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 240 | 240 | 240 | 238 | 238 | 237 | 237 | 236 | 235 | 233 | 232 | 233 | ||||||
| Retained Earnings Accumulated Deficit | -221 | -218 | -215 | -212 | -211 | -208 | -158 | -158 | -153 | -150 | -146 | -144 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -12 | -12 | -12 | -12 | -12 | -14 | -16 | -13 | -15 | -15 | -14 | -15 | ||||||
| Stockholders Equity | 7 | 10 | 14 | 14 | 16 | 15 | 63 | 65 | 67 | 69 | 73 | 74 | ||||||
| Liabilities And Stockholders Equity | 76 | 78 | 80 | 78 | 80 | 80 | 127 | 131 | 129 | 133 | 137 | 140 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock No Par Value | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | ||||||
| Common Stock Shares Issued | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Shares Outstanding | 5 | 45 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialHARVARD BIOSCIENCE INC (HBIO) — SEC Financial Statements & Analysis
HARVARD BIOSCIENCE INC (HBIO) is a laboratory analytical instruments company, incorporated in DE. HARVARD BIOSCIENCE INC trades on Nasdaq as: HBIO. HARVARD BIOSCIENCE INC (HBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, HARVARD BIOSCIENCE INC carries a market cap of $27.83M, a P/E ratio of -2.67x, a P/B ratio of 3.75x, a P/S ratio of 0.32x, an enterprise value of $58.01M, and an EV/EBITDA multiple of 37.53x. On profitability, it posts a gross margin of 58.16%, an operating margin of -0.28%, a net margin of -11.86%, a Return on Equity (ROE) of -89.95%, a Return on Assets (ROA) of -13.32%, and a Return on Invested Capital (ROIC) of -0.57%. Per share, it reports EPS of $-2.30, diluted EPS of $-2.01, free cash flow per share of $-0.25, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -1.06% year-over-year, net income growth of -81.86% year-over-year, and EPS growth of -82.25% year-over-year. On the balance sheet, it maintains a current ratio of 1.87x, a quick ratio of 0.98x, working capital of $21.67M, a debt-to-equity ratio of 9.28x, a debt ratio of 0.9, an interest coverage ratio of -0.04x, free cash flow of $-1.12M (TTM), and net debt of $30.18M. Figures sourced from SEC EDGAR.
- Market Cap
- $27.83M
- P/E TTM
- -2.67x
- EPS TTM
- $-2.30
- P/B TTM
- 3.75x
- ROE TTM
- -89.95%
- ROA TTM
- -13.32%
- Debt To Equity
- 9.28x
- Free Cash Flow TTM
- $-1.12M
- Net Revenue TTM Growth 1Y
- -1.06%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HARVARD BIOSCIENCE INC in?
HARVARD BIOSCIENCE INC (HBIO) operates in the Laboratory Analytical Instruments industry.
What exchange does HBIO trade on?
HARVARD BIOSCIENCE INC (HBIO) trades on the Nasdaq.
Where is HARVARD BIOSCIENCE INC incorporated?
HARVARD BIOSCIENCE INC is incorporated in DE.
When was HARVARD BIOSCIENCE INC (HBIO)'s most recent SEC filing?
HARVARD BIOSCIENCE INC (HBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is HBIO's market cap?
HARVARD BIOSCIENCE INC (HBIO) has a market capitalization of $27.83M as of 2026-06-30.
What is HBIO's EPS (earnings per share)?
HARVARD BIOSCIENCE INC (HBIO)'s trailing twelve month EPS is $-2.30 as of 2026-06-30.
What is HBIO's ROE (return on equity)?
HARVARD BIOSCIENCE INC (HBIO)'s trailing twelve month Return on Equity (ROE) is -89.95% as of 2026-06-30.
What is HBIO's ROA (return on assets)?
HARVARD BIOSCIENCE INC (HBIO)'s trailing twelve month Return on Assets (ROA) is -13.32% as of 2026-06-30.
What is HBIO's ROIC (return on invested capital)?
HARVARD BIOSCIENCE INC (HBIO)'s trailing twelve month Return on Invested Capital (ROIC) is -0.57% as of 2026-06-30.
What is HBIO's EV/EBITDA?
HARVARD BIOSCIENCE INC (HBIO)'s trailing twelve month EV/EBITDA is 37.53x as of 2026-06-30.